What is Elevance Health's forward P/E?

Elevance Health's forward P/E is 14.14: today's price over the analysts' average EPS estimate for the next twelve months, the earnings expected rather than those reported. By fiscal year, it trades at 14.6 times its FY2026 earnings and 14.1 times its FY2027 earnings.

What is Elevance Health's PEG ratio?

Elevance Health's PEG ratio is 1.61: its P/E of 18.11 over the 11.3% a year the analysts expect its earnings per share to grow from FY2025 to FY2028. Around 1 is often read as a P/E in line with the growth; above it, the price asks for more.

Elevance Health
D
Quotes are delayed by 15 minutes

ELV

Arincen ScoreBeta57/100

57/100B

425.34

USD

-4.40

(-1.02%)

Market Open

Last updated: 13 Nov, 10:10 GMT-5 · Delayed 15 min

Fair value401.93Plus+6%262Price 425.34501

Q4 FY2026 · Earnings report

EPS estimate 2.08Revenue estimate 49.38B

Q4 FY2026 · Earnings report

Wednesday 27 January

EPS estimate 2.08Revenue estimate 49.38B

Fair value401.93Plus+6%262Price 425.34501

Q4 FY2026 · Earnings report

EPS estimate 2.08Revenue estimate 49.38B

Q4 FY2026 · Earnings report

Wednesday 27 January

EPS estimate 2.08Revenue estimate 49.38B

Overview Financials News Forecast Earnings Dividends Company

Elevance Health P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

Elevance Health's P/E ratio is 18.11: its share price of 425.34 over its earnings per share of 23.48 over the last twelve months.

Today: 18.11
Forward P/E, next 12 months: 14.14
PEG ratio: 1.61
Median, 5 years: 17.12
Low, 5 years: 11.16
High, 5 years: 21.35

P/E ratio = price ÷ EPS (last 12 months) = 425.34 ÷ 23.48 = 18.11

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Elevance Health's P/E high compared with its own history?Is the P/E high or low for this stock? Today's P/E against every daily P/E of the stock's last 5 years, with the growth analysts expect: whether the stock is expensive or cheap compared with itself, and whether its growth explains it.

Elevance Health's P/E of 18.1 is above the middle of its 5-year range (11.2 to 21.4, median 17.1). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history.

5-year range of the daily P/E

Median 17.1

Today 18.1

11.2

21.4

The price against its P/E range

At its 5-year high P/E (21.4)At its median P/E (17.1)At its 5-year low P/E (11.2)Price

Each line is the earnings per share of the day times one P/E of the last five years: the price near the top line is near the most it was paid for those earnings, near the bottom line the least.

Growth a year: the past against what analysts expect

EPSFaster
Expected, to FY2028 11.3%Past 5 years 6.9%Past 3 years 1.1%
RevenueSlower
Expected, to FY2028 2.3%Past 5 years 10.3%Past 3 years 8.3%

	Past 5 years	Past 3 years	Expected, to FY2028	Expected against the past
EPS	6.9%	1.1%	11.3%	Faster
Revenue	10.3%	8.3%	2.3%	Slower

Buyers pay less for each point of growth than usual: a PEG of 1.6 on expected growth against 2.5 on its median P/E and past five years' growth.

What changed in 5 years

Debt is higher than in FY2020: 3.4 times EBITDA against 2.7.
Buybacks: EPS grew ⁦6.9%⁩ a year since FY2020 against ⁦4.4%⁩ for net income; the falling share count added about 2.5 points a year.
Operating margin is lower than in FY2020: ⁦4.1%⁩ against ⁦6.3%⁩.
Unusual tax: FY2025 at ⁦15.6%⁩ against a usual ⁦22.8%⁩, which moves that year's profit and the P/E readings that include it.
Health Benefits Segment grew from ⁦0.0%⁩ of revenue in FY2020 to ⁦70.0%⁩ in FY2025.
Since 15 November 2021 the price has changed ⁦−2.1%⁩: earnings per share ⁦+4.0%⁩ and the P/E ⁦−5.9%⁩.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal year	Period ending	P/E ratio	Forward P/E	Market cap	Net income
FY2027 · Estimate	31 Dec 2027	14.06	—	—	—
FY2026 · Estimate	31 Dec 2026	14.64	—	—	—
Today		18.11	14.14	91.90B	5.10B
FY2025	31 Dec 2025	13.73	12.06	77.75B	5.66B
FY2024	31 Dec 2024	14.39	15.52	85.90B	5.97B
FY2023	31 Dec 2023	18.36	15.52	109.91B	5.99B
FY2022	31 Dec 2022	20.45	15.52	123.11B	6.02B
FY2021	31 Dec 2021	18.54	15.97	113.01B	6.10B
FY2020	31 Dec 2020	17.61	12.38	80.53B	4.57B
FY2019	31 Dec 2019	16.05	13.52	77.17B	4.81B
FY2018	31 Dec 2018	17.81	13.52	66.79B	3.75B
FY2017	31 Dec 2017	14.99	14.33	57.62B	3.84B
FY2016	31 Dec 2016	15.35	11.99	37.92B	2.47B
FY2015	31 Dec 2015	14.23	12.83	36.43B	2.56B
FY2014	31 Dec 2014	13.13	12.35	33.69B	2.57B
FY2013	31 Dec 2013	9.99	11.68	27.10B	2.71B
FY2012	31 Dec 2012	6.99	10.41	18.56B	2.66B
FY2011	31 Dec 2011	8.49	9.77	22.48B	2.65B
FY2010	31 Dec 2010	7.44	9.48	21.48B	2.89B
FY2009	31 Dec 2009	5.93	10.85	28.17B	4.75B
FY2008	31 Dec 2008	8.87	10.33	22.09B	2.49B
FY2007	31 Dec 2007	15.56	15.04	52.06B	3.35B
FY2006	31 Dec 2006	15.96	14.19	49.40B	3.09B
FY2005	31 Dec 2005	19.80	17.24	48.78B	2.46B
FY2004	31 Dec 2004	16.55	14.94	15.90B	960.90M
FY2003	31 Dec 2003	13.39	12.06	10.37B	774.30M
FY2002	31 Dec 2002	43.49	12.68	7.48B	171.90M
FY2001	31 Dec 2001	14.95	—	5.12B	342.20M
FY2000	31 Dec 2000	18.66	—	4.22B	226.00M
FY1999	31 Dec 1999	93.90	—	4.22B	44.90M
FY1998	31 Dec 1998	24.46	—	4.22B	172.40M

Quarter	Period ending	P/E ratio	Forward P/E	Market cap	Net income
Q3 FY2026	30 Sept 2026	16.58	12.99	84.61B	5.10B
Q2 FY2026	30 Jun 2026	17.03	13.05	84.27B	4.95B
Q1 FY2026	31 Mar 2026	12.32	9.98	64.52B	5.24B
Q4 FY2025	31 Dec 2025	13.73	12.06	77.75B	5.66B
Q3 FY2025	30 Sept 2025	13.20	11.03	72.96B	5.53B
Q2 FY2025	30 Jun 2025	16.42	13.17	87.83B	5.35B
Q1 FY2025	31 Mar 2025	16.67	14.62	98.47B	5.91B
Q4 FY2024	31 Dec 2024	14.05	15.52	83.92B	5.97B
Q3 FY2024	30 Sept 2024	18.97	15.52	121.17B	6.39B
Q2 FY2024	30 Jun 2024	18.58	15.52	124.12B	6.68B
Q1 FY2024	31 Mar 2024	19.25	15.52	120.07B	6.24B
Q4 FY2023	31 Dec 2023	18.35	15.52	109.91B	5.99B
Q3 FY2023	30 Sept 2023	16.74	15.52	102.45B	6.12B
Q2 FY2023	30 Jun 2023	16.34	15.52	105.12B	6.43B
Q1 FY2023	31 Mar 2023	17.58	15.52	109.20B	6.21B
Q4 FY2022	31 Dec 2022	20.33	15.52	122.07B	6.00B
Q3 FY2022	30 Sept 2022	17.65	14.19	108.84B	6.17B
Q2 FY2022	30 Jun 2022	19.18	15.55	116.16B	6.06B
Q1 FY2022	31 Mar 2022	19.06	16.36	118.58B	6.22B
Q4 FY2021	31 Dec 2021	18.39	15.97	112.07B	6.10B
Q3 FY2021	30 Sept 2021	16.44	13.19	90.74B	5.52B
Q2 FY2021	30 Jun 2021	22.01	13.90	93.35B	4.24B
Q1 FY2021	31 Mar 2021	18.65	13.44	87.94B	4.72B
Q4 FY2020	31 Dec 2020	17.23	12.38	78.80B	4.57B
Q3 FY2020	30 Sept 2020	13.61	10.73	67.42B	4.96B
Q2 FY2020	30 Jun 2020	11.21	10.88	66.32B	5.92B
Q1 FY2020	31 Mar 2020	11.99	9.73	57.30B	4.78B
Q4 FY2019	31 Dec 2019	15.89	13.52	76.39B	4.81B
Q3 FY2019	30 Sept 2019	14.26	13.52	61.27B	4.30B
Q2 FY2019	30 Jun 2019	17.81	13.52	72.57B	4.07B
Q1 FY2019	31 Mar 2019	18.59	13.52	74.13B	3.99B
Q4 FY2018	31 Dec 2018	18.02	13.52	67.59B	3.75B
Q3 FY2018	30 Sept 2018	15.73	14.84	71.67B	4.56B
Q2 FY2018	30 Jun 2018	14.18	13.56	61.58B	4.34B
Q1 FY2018	31 Mar 2018	13.56	13.22	56.20B	4.15B
Q4 FY2017	31 Dec 2017	14.99	14.33	57.62B	3.84B
Q3 FY2017	30 Sept 2017	16.40	12.86	48.88B	2.98B
Q2 FY2017	30 Jun 2017	17.46	13.59	49.78B	2.85B
Q1 FY2017	31 Mar 2017	15.75	12.81	43.73B	2.78B
Q4 FY2016	31 Dec 2016	15.35	11.99	37.92B	2.47B
Q3 FY2016	30 Sept 2016	14.45	10.70	32.98B	2.28B
Q2 FY2016	30 Jun 2016	14.89	11.49	34.54B	2.32B
Q1 FY2016	31 Mar 2016	15.24	12.47	36.53B	2.40B
Q4 FY2015	31 Dec 2015	14.23	12.83	36.43B	2.56B
Q3 FY2015	30 Sept 2015	12.68	13.09	36.58B	2.89B
Q2 FY2015	30 Jun 2015	15.09	15.61	43.19B	2.86B
Q1 FY2015	31 Mar 2015	15.06	14.92	41.17B	2.73B
Q4 FY2014	31 Dec 2014	13.05	12.35	33.50B	2.57B
Q3 FY2014	30 Sept 2014	13.32	12.45	32.36B	2.43B
Q2 FY2014	30 Jun 2014	12.03	11.91	29.54B	2.46B
Q1 FY2014	31 Mar 2014	11.12	11.75	28.06B	2.52B
Q4 FY2013	31 Dec 2013	9.61	11.68	26.05B	2.71B
Q3 FY2013	30 Sept 2013	8.83	11.31	24.76B	2.81B
Q2 FY2013	30 Jun 2013	8.61	11.93	24.45B	2.84B
Q1 FY2013	31 Mar 2013	7.62	10.44	20.45B	2.68B
Q4 FY2012	31 Dec 2012	6.96	10.41	18.47B	2.66B
Q3 FY2012	30 Sept 2012	7.21	9.53	18.21B	2.53B
Q2 FY2012	30 Jun 2012	8.30	10.09	20.90B	2.52B
Q1 FY2012	31 Mar 2012	9.50	11.26	24.49B	2.58B
Q4 FY2011	31 Dec 2011	8.31	9.77	21.98B	2.65B
Q3 FY2011	30 Sept 2011	8.13	9.92	23.24B	2.86B
Q2 FY2011	30 Jun 2011	9.89	12.33	28.84B	2.92B
Q1 FY2011	31 Mar 2011	8.76	11.27	25.73B	2.94B
Q4 FY2010	31 Dec 2010	7.26	9.48	20.96B	2.89B
Q3 FY2010	30 Sept 2010	4.40	9.70	22.36B	5.08B
Q2 FY2010	30 Jun 2010	4.26	8.61	21.58B	5.07B
Q1 FY2010	31 Mar 2010	5.63	11.65	28.40B	5.04B
Q4 FY2009	31 Dec 2009	5.42	10.85	25.71B	4.75B
Q3 FY2009	30 Sept 2009	9.56	9.39	22.33B	2.34B
Q2 FY2009	30 Jun 2009	10.40	10.78	25.24B	2.43B
Q1 FY2009	31 Mar 2009	7.58	8.63	18.83B	2.48B
Q4 FY2008	31 Dec 2008	8.39	10.33	20.90B	2.49B
Q3 FY2008	30 Sept 2008	7.96	10.34	24.02B	3.02B
Q2 FY2008	30 Jun 2008	8.08	9.60	24.77B	3.07B
Q1 FY2008	31 Mar 2008	7.60	8.17	23.95B	3.15B
Q4 FY2007	31 Dec 2007	14.28	15.04	47.77B	3.35B
Q3 FY2007	30 Sept 2007	14.16	13.70	46.56B	3.29B
Q2 FY2007	30 Jun 2007	15.07	14.03	48.67B	3.23B
Q1 FY2007	31 Mar 2007	15.76	14.43	49.62B	3.15B
Q4 FY2006	31 Dec 2006	15.56	14.19	48.14B	3.09B
Q3 FY2006	30 Sept 2006	16.20	14.50	47.69B	2.94B
Q2 FY2006	30 Jun 2006	16.41	14.31	45.55B	2.78B
Q1 FY2006	31 Mar 2006	19.59	15.94	50.59B	2.58B
Q4 FY2005	31 Dec 2005	21.16	17.24	52.13B	2.46B
Q3 FY2005	30 Sept 2005	23.14	17.10	46.26B	2.00B
Q2 FY2005	30 Jun 2005	26.49	16.44	42.34B	1.60B
Q1 FY2005	31 Mar 2005	29.73	15.51	37.96B	1.28B
Q4 FY2004	31 Dec 2004	36.65	14.94	35.22B	960.90M
Q3 FY2004	30 Sept 2004	12.33	11.91	12.14B	984.40M
Q2 FY2004	30 Jun 2004	13.19	12.88	12.39B	938.80M
Q1 FY2004	31 Mar 2004	14.29	13.76	12.55B	878.20M
Q4 FY2003	31 Dec 2003	13.38	12.06	10.36B	774.30M
Q3 FY2003	30 Sept 2003	13.39	12.09	9.87B	737.40M
Q2 FY2003	30 Jun 2003	15.01	13.81	10.69B	712.10M
Q1 FY2003	31 Mar 2003	14.36	12.57	9.20B	641.00M
Q4 FY2002	31 Dec 2002	15.91	12.68	8.74B	549.10M
Q3 FY2002	30 Sept 2002	18.00	13.99	8.37B	464.90M
Q2 FY2002	30 Jun 2002	16.35	—	6.63B	405.20M
Q1 FY2002	31 Mar 2002	—	—	6.02B	—
Q4 FY2001	31 Dec 2001	—	—	5.09B	—
Q3 FY2001	30 Sept 2001	—	—	4.22B	—
Q1 FY2001	31 Mar 2001	—	—	0.00	—

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

Common questions about Elevance Health's P/E ratio

Source: Financial Modeling Prep

Elevance Health
D
Quotes are delayed by 15 minutes

ELV

Elevance Health P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

Is Elevance Health's P/E high compared with its own history?Is the P/E high or low for this stock? Today's P/E against every daily P/E of the stock's last 5 years, with the growth analysts expect: whether the stock is expensive or cheap compared with itself, and whether its growth explains it.

The price against its P/E range

Growth a year: the past against what analysts expect

What changed in 5 years

P/E ratio by year and by quarter

Common questions about Elevance Health's P/E ratio

What is Elevance Health's P/E ratio?

Is Elevance Health's P/E ratio high or low?

What is Elevance Health's forward P/E?

What is Elevance Health's PEG ratio?

Need help?

Elevance Health DQuotes are delayed by 15 minutes

ELV

Elevance Health P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

Is Elevance Health's P/E high compared with its own history?Is the P/E high or low for this stock? Today's P/E against every daily P/E of the stock's last 5 years, with the growth analysts expect: whether the stock is expensive or cheap compared with itself, and whether its growth explains it.

P/E ratio by year and by quarter

Common questions about Elevance Health's P/E ratio

What is Elevance Health's P/E ratio?

Is Elevance Health's P/E ratio high or low?

What is Elevance Health's forward P/E?

What is Elevance Health's PEG ratio?

Need help?

Elevance Health
D
Quotes are delayed by 15 minutes